Clinical trial
Benefits of Microcor in Ambulatory Decompensated Heart Failure
NCT04096040 · Zoll Medical Corporation, Industry · Completed
Key facts
| NCT number | NCT04096040 |
|---|---|
| Title | Benefits of Microcor in Ambulatory Decompensated Heart Failure |
| Official title | Benefits of Microcor in Ambulatory Decompensated Heart Failure |
| Acronym | BMAD-TX |
| Lead sponsor | Zoll Medical Corporation, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Heart Failure |
| Intervention type | Device |
| Interventions | μCor |
| Enrollment | 265 |
| Start date | Nov 1, 2019 |
| Primary completion | Jun 30, 2023 |
| Completion | Oct 30, 2023 |
| First posted | Sep 19, 2019 |
| Last update posted | Jan 8, 2025 |
| Countries | Austria, France, Germany, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: